Profits >
Followers | 93 |
Posts | 1,750 |
Boards Moderated | 0 |
Alias Born | 04/16/2014 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Today’s tweet from the company
“OTC Markets has updated the share structure for Bebida Beverage Company.
Thank you for your patronage and patience, have a wonderful week!
Courtesy IR”
3/14/19
$BBDA
DSCR JOINT VENTURE COMPLETE NEWS
Monday, March 11 2019 8:30 AM, EST Discovery Minerals Ltd. Announces Completion of Joint Venture for Mining War Eagle Mountain Project GlobeNewswire "Press Releases"
The Company Has Completed a Definitive Joint Venture Agreement with the Owners of the War Eagle Mountain Project to Fully Explore, Mine, and Process Ore Bodies. The Joint Venture Includes the Existing Mill Facility
PHOENIX, AZ , March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE Discovery Minerals Ltd. (OTCQB: DSCR) an acquisition and development Company that targets natural resource properties primarily in precious metals and mining operations. Discovery Minerals is pleased to announce that they have completed a Joint Venture with the Owners of the War Eagle Mountain Project . Under the terms of the Joint Venture Discovery Minerals will be the operator of the mine and receive 50% of all net proceeds. The Owners have contributed their mining claims as well as the existing Mill Facility located on Silver City Road .
Russell Smith, CEO of Discovery Minerals , stated; It has been a pleasure working with the owners of the War Eagle Mountain Project . War Eagle Mountain is a proven resource for Gold and Silver deposits and we are truly benefiting from the extensive historical operation reports and geology already completed as well as the owners knowledge of this rich project. The inclusion of the Mill Facility in the Joint Venture was extremely important as it will allow us to focus resources on commencing mining operations. Now that the Joint Venture agreement has been fully documented we will look to accelerate completion of the first phase mining plan. As previously announced our initial mining target is an extension of the Ore Fino Vein with approximately 70,000 tons of near surface ore. Girvan Jackson , Project Manager, and myself have already scheduled an immediate site visit with the geologists and mill engineer with a view to expedite the mining and precious metal production plan. We look forward to reporting compilation of the mining plan on schedule in April 2019 as well as other considerations to expand early operations and continue to create long term shareholder value.
About Discovery Minerals Ltd. :
Discovery Minerals Ltd. (OTC PINK: DSCR) is an acquisition and development company that targets natural resource properties and cutting edge technology opportunities through its subsidiaries. The Board of Directors has determined that these activities be continued with an emphasis on early positive cash flow from any projects undertaken. Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact: Discovery Minerals Ltd. Info@discoveryminerals.com
Source: Discovery Minerals Ltd
VSPC NEWS
Monday, March 11 2019 7:00 AM, EST VIASPACE Completes Acquisition Of Elite Therapeutics And Bad Love Cosmetics Company, LLC PR Newswire "Press Releases US - English"
SANTA CRUZ, Calif. , March 11, 2019 /PRNewswire/ -- VIASPACE, Inc. (OTC: VSPC) today announced that on March 06, 2019 , it completed the purchase of luxury cosmetics company Elite Therapeutics (www.elitetherapeutics.com) in an all stock acquisition/transaction. Elite Therapeutics was founded in 2007 as Bad Love Cosmetics Company, LLC and began doing business as Elite Therapeutics with high quality, results-driven, medical grade cosmetics in late 2010. Elite Therapeutics has a full line of luxury products for personal use and high-end hotel amenities. In 2018, the company developed a new ultra-lux, hemp-derived "CBD Recovery Crme" which was launched on February 04, 2019 to rave reviews. It uses a highly-purified, hemp-derived, THC-free CBD isolate and is of the same high quality as the entire, physician-designed Elite Therapeutics product line.
VIASPACE and VIASPACE executives have also established a special purposes company named " Viaspace California, Inc. " that is proceeding with plans to grow its first 100 acres of hemp in Southern California this year with business objectives to process hemp for Cannabidiol (CBD), selling or licensing name-brand hemp seeds and other commercial uses. As VIASPACE -owned Elite Therapeutics and Bad Love Cosmetics develop and deploy their physician-designed CBD cosmetic product lines, they will be primary consumers of Viaspace California, Inc. , hemp-derived CBD.
VIASPACE Board Chairman and Acting CEO, Dr. Kevin Schewe , commented, "The U.S. farm bill made Hemp a legal agricultural product in all 50 states in December 2018 . In addition to providing a steady and increasing revenue stream for 2019 and beyond, this strategic acquisition of Elite Therapeutics and Bad Love Cosmetics Company, LLC , positions VIASPACE as a producer of luxury CBD cosmetics at a time when the CBD cosmetics industry is in its relative infancy and exploding with products. A recent cosmetic skin care sector article projected that the U.S. national market for hemp-derived CBD is expected to increase to $7 billion by the year 2023, and in 10 years it will be a completely normalized cosmetic product. We believe that our flagship Elite "CBD Recovery Crme" is of world class quality and performance and sets a very high bar as an effective, physician-designed CBD cosmetic crme. The packaging is worthy of high-end retail and each 50 ml container has 377 mg of activated CBD hemp extract contained within the ingredient base of our time-tested and successful Elite Premier Crme."
Dr. Schewe continued, "In addition to the acquisition of Elite Therapeutics, the all stock purchase by VIASPACE has also included acquiring Bad Love Cosmetics Company, LLC . In the of Elite Therapeutics' luxury cosmetic products, high-end hotel amenity line and brand new CBD Recovery Crme; Bad Love Cosmetics has been developing an interesting and edgy line of lip care products that are perfectly suited for the CBD cosmetic universe. The Bad Love CBD lip product line project is close to launching and is part of our business plan for 2019. Given the early but huge potential of the CBD cosmetic product industry, VIASPACE is open to potential partnerships and/or licensing agreements with larger, established cosmetic companies as we build our CBD cosmetic portfolio."
About VIASPACE Inc. VIASPACE grows renewable Giant King Grass as a low-carbon fuel for clean electricity generation; for environmentally friendly energy pellets; and as a feedstock for bio-methane production and for green cellulosic biofuels, biochemicals and biomaterials. Giant KingGrass is a proprietary, high yield, dedicated biomass energy crop. Giant King Grass when it is cut frequently at 4 to 5 feet tall is also excellent animal feed. The USDA granted approval for planting Giant King Grass throughout the US and cooperates in exporting by performing the required inspections and issuing the phytosanitary certificate needed for import into foreign countries. Giant King Grass is being grown in the US including Hawaii , and many foreign countries. For more information, please go to www.VIASPACE.comor contact Dr. Jan Vandersande , Director of Communications, at 800-517-8050 or IR@VIASPACE.com.
About Elite Therapeutics Elite Therapeutics, founded by Board Certified radiation oncologist, Dr. Kevin Schewe , is a clinical and cosmetic skincare company dedicated to delivering true and visible results. With over 32 years of clinical oncology experience, he made it his mission to offer patients relief and restoration from the external effects of treatment during their internal fight for life.Dr. Schewe searched for ingredients that would provide immediate nurturing on the surfacethen continue working at the cellular level for long-term healing; this includes a new, high-potency CBD Recovery Crme. The full body and hair care product line can be purchased at retailers across the country as well as on the website (http://www.elitetherapetics.com). Elite Therapeutics also provides custom luxury amenities for high-end hotels and rental properties. For more information or wholesale inquiries, please visit the website or contact us at: https://elitetherapeutics.com/pages/contact-us.
Safe Harbor Statement Information in this news release includes forward-looking statements. These forward-looking statements relate to future events or future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Such factors include, without limitation, risks outlined in our periodic filings with the U.S. Securities and Exchange Commission , including Annual Report on Form 10-K for the year ended December 31, 2017 , and other factors over which VIASPACE has little or no control.
View original content:http://www.prnewswire.com/news-releases/viaspace-completes-acquisition-of-elite-therapeutics-and-bad-love-cosmetics-company-llc-300809648.html
SOURCE VIASPACE Inc.
Valuable information thank you
Patience pays they delivered
Completely agree!
We tried our best to warn all to trust the dd here!
Last week they waited until after the market closed to tweet of a acquisition of a company with 10mil in revs and 50mil in assets.
So I wouldn’t mind as well if they wait until then.
If they company wasn’t transparent it wouldn’t be assuring to shareholders.
Lucky for us they have been.
IMPORTANT THOUGHTS
Waiting a few more days to go current does not mean he has con us. It means exactly what the tweet stated
“Our accountant and attorney are actively working to finalize our annual report and attorney letter, and should be uploaded to OTC Markets next week," said Mr. Bolbat
$LEAS Shareholders can now confirm the OTC Profile is "Verified"
Courtesy IR”
Waiting a few more days because they can not move things as quickly as they thought I have no problem waiting. Many miss out because they are impatient company has also still provided their updates share structure on the otc markets.
O/s is still 751,861,360 dated 3/7/19
https://www.otcmarkets.com/stock/LEAS/security
Which is awesome!
Let’s also keep in mind that per the company’s tweet
“The merging corporation will be released once the company is Pink Current, any news released prior to current; could result in a Caveat Emptor status with OTC-M." Mr. Bolbat continued, "The incoming business has $50 Million in assets and $10 Million in annual revenues." $LEAS”
So after going current we can expect the company details to be fully announced.
ALSO WITH ANY DILUTION RUMORS THE COMPANY HAS SPOKEN ON THAT AS WELL
The Company has not diluted shares into the market, any trading activity is strictly retail.
We will not tweet or release news that could be considered promotional. (Factual information only)
The accountant and attorney are doing their jobs.
Thank you! Mr. Bolbat -MARCH 6
With all this pending and this small share structure this current price is in my option extremely cheap.
Thank you stervc I appreciate it.
Completely agree well said.
GNCP RECENT UPDATES
-FEB 21st -GNCC Capital, Inc. (OTC: GNCP) released a detailed OTC Market Filing in respect of the acquisition on BioCann Pharma S.A.S. A link to this Filing:
https://backend.otcmarkets.com/otcapi/company/financial-report/212241/content
https://www.prnewswire.com/news-releases/gncc-capital-inc-acquires-biocann-pharma-sas-300799508.html
-FEB 28th- GNCC Capital, Inc. (OTC: GNCP) confirms completion of acquisition of BioCann Pharma S.A.S. and other matters, a link:
http://www.otcmarkets.com/financialReportViewer?id=212675
-FEB 28th- GNCC Capital, Inc. (OTC: GNCP) confirms number of Issued and Outstanding Common Stock. A link:
http://www.otcmarkets.com/financialReportViewer?id=212686
-MARCH 1st-GNCC Capital, Inc. can now confirm that commencing next week, the BioCann Pharma Management Team will be familiarizing GNCC stockholders with their business and prospects. Only on National Distribution Press Releases. They appoint their first Director to GNCC Board on Monday.
-MARCH 3rd- GNCC Capital, Inc. (OTC: GNCP) sets out actions being undertaken this coming week, a link:
http://www.otcmarkets.com/financialReportViewer?id=212957
-MARCH 4th- GNCC Capital, Inc. (OTC: GNCP) joints OTC Markets Group "Transfer Agent Verified Shares Program" with immediate effect, a link:
https://backend.otcmarkets.com/otcapi/company/financial-report/212971/content
-MARCH 6th- GNCC Capital, Inc. (OTC: GNCP) confirms the appointment of the first BioCann Pharma Executive to the GNCC Capital, Inc. Board of Directors, a link:
http://www.otcmarkets.com/financialReportViewer?id=213059
-MARCH 6th- GNCC Capital, Inc. (OTC: GNCP) reiterates its position that it will not provide the dates and times of upcoming Press Releases. Public information will be released without any prior warnings to any shareholder or to any other party.
-Management also stated if you have any questions
Shareholders are encouraged to E Mail all of their questions and/or clarification of hard facts to: investor@gncc-capital.com.
ETFM
Thursday, March 07 2019 2:02 PM, EST 2050 MOTORS, INC. FILES (8-K) Disclosing Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits Edgar Online "Glimpses"
Item 4.01 Changes in Registrant's Certifying Accountant.
On February 27, 2019 , Farber, Hass, Hurley LLP announced that the auditor-client relationship with 2050 Motors, Inc. (Commission File Number: 0-192227) has ceased as of February 26, 2019 . There were no disagreements about accounting issues.
Item 5.01 Changes in Control of Registrant.
In accordance with Item 5.01 Changes in Control of Registrant and as part of this transition plan, current management and the Board are simultaneously tendering their resignations from the Company ETFM on March 6, 2019 . By no later than March 15, 2019 , as majority shareholder in ETFM, you will prepare Agreement between ETFM, public corporation, which owns the exclusive license and rights to the Jiangsu Aoxin New Energy Automobile Co., Ltd. , (Aoxin) to import, distribute and assemble their automobiles in the USA and subsidiary, Nevada private corporation, 2050 Motors, Inc. (TFPC) for the following:
As consideration, 2050 Motors, Inc. (ETFM) will transfer to current Management and Investors, to be determined in TFPC, eighty (80) percent ownership in exchange for retaining a twenty (20) percent ownership interest in 2050 Motors, Inc. , Private Corporation (TFPC) and corporate note from TFPC in the amount of Fifty ($50K) thousand dollars at 8% interest per annum to be paid out of net profits. ETFM will appoint William L. Fowler as President of 2050 Motors, Inc. private Nevada corporation (TFPC) to raise operating capital for expenses to negotiate terms and conditions to maintain Exclusive License with Aoxin.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 6, 2019 , Mr. William L. Fowler resigned his positions as President/CEO along with any other executive officer positions he held with the Company. The Board, in the best interest of the Company, accepted Mr. Fowler's resignation and thanked him for his service on behalf of the Company.
On March 6, 2019 , in the best interest of the Company, the Board of Directors also appointed Vikram Grover to the positions of President/CEO, Secretary, Treasurer, Chief Financial Officer, and as Board Member of the Company. Following is some information on Mr. Grover :
Vikram Grover
Mr. Grover is a seasoned Wall Street veteran with over two decades of experience as a sell-side research analyst and investment banker at technology-focused brokerage firms, including Needham & Co. and Thomas Weisel Partners (now Stifel Nicolaus ). He is familiar with small-cap public company finance and has a broad network of money managers, family offices, high net worth investors, strategic partners and M&A targets in the U.S. and abroad. Mr. Grover has a M.S. in Management from the Georgia Institute of Technology and is a Chartered Financial Analyst (CFA).
Mr. Grover will serve until the next annual meeting of stockholders of the Company and until such officer's and/or director's successor is elected and qualified or until such officer's and/or director's earlier death, resignation or removal.
Presently, the commitments with regard to compensation or remuneration for Mr. Grover are as follows:
1) Granting Vikram Grover the compensation package of 100 million common stock purchase warrants with a strike price of $0.001 (one tenth of a cent) and a 5-year expiration date. Vesting date and start date of the five-year expiration period will commence when the Company is brought fully-reporting and current with its required SEC filings (i.e., forms 10-Q, 10-K, etc.) The number of warrants will be doubled at the end of the first year from issuance if at any time from issuance of the initial warrants, ETFM's closing bid price is greater than one cent ( $0.01 ) for 10 consecutive business days / trading sessions.
2) Assignment of nine (9) million shares of Preferred Stock in 2050 Motors, Inc. at a 50 to 1 ratio (representing 450,000,000 votes) to the order of Vikram Grover .
The Company has no employee benefit plans or other compensation plans.
On March 6, 2019 , Mr. Bernd Schaefers resigned his positions as Board Member and Secretary along with any other executive officer positions he held with the Company. The Board, in the best interest of the Company, accepted Mr. Schaefers' resignation and thanked him for his service on behalf of the Company.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description 99.1 Vikram Grover Employment Contract dated March 5, 2019 .
Alias born : 3/6/19 @ 10:39am
Welcome to iHub sir
Bid 612million
Ask 114million
XDSL ACQUISITION NEWS
Thursday, March 07 2019 9:02 AM, EST MPHASE TECHNOLOGIES, INC. ACQUIRES TRAVEL BUDDHI GlobeNewswire "Press Releases"
New York, NY , March 07, 2019 (GLOBE NEWSWIRE) -- mPhase Technologies, Inc. (OTC:XDSL) (mPhase or the Company) is pleased to announce the acquisition of Travel Buddhi, a technology platform focused on enhancing travel via ultra-customization tools that can tailor the travel experience in ways not previously available. The technology was originally developed by members of the new mPhase Technologies India (MTI) team and will be commercialized by that Division during 2019. This acquisition represents the first tangible product line to utilize mPhases growing commitment to develop real-world products via an in-house team of machine learning and artificial intelligence (AI) experts.
Travel Buddhi represents a revolutionary concept in the travel industry because it is designed to understand a travelers profile and react in real time to changes during travel, all while staying within the confines of personal preference and budget. The service uses proprietary software to offer curated content, craft optimized itineraries, provide multiple booking options and track the user experience. Travel Buddhi represents a brand-new style of travel planning, where an enhanced travel experience can extend from the planning stage all of the way through the end of each journey.
This is a highly monetizable platform that can direct more layers of consumer spending during travel than other competing services. Hospitality, entertainment, retail, and transportation companies reward channels that drive traffic to their venues, so maximizing the number of those venues is a major benefit of this technology, explained CEO Bhatnagar. Imagine an AI-driven concierge that travels with you and can direct you to the best fit in terms of where you will stay, how you will get there, where you will eat, and what you will do all to fit your budget, needs and desires. The site makes travel easier as a start, but also exposes users to experiences they might otherwise miss.
Built on AI-powered itinerary algorithms, Travel Buddhi offers an industry-leading level of customization that allows collaborative trip planning (among family and friends) and crafts a fully customizable experience far beyond the bounds of other sites, which often end at the rental car counter or hotel lobby. In addition to its own technology-driven suggestions, the site also features a unique layer of travel hosts travel agents, hotel concierges, guides and enthusiasts who can offer local expertise.
The formation of the MTI Division and our recently announced Center of Excellence for machine learning and AI, are part of our new strategy to 1) commercialize our exiting IP and 2) to develop new technologies that can be leveraged and commercialized to become revenue-producing. We intend to use Travel Buddhi as a showcase for this effort, but it is just the first of what we hope will be a steady stream of innovative products, said mPhase CEO Anshu Bhatnagar . Our strategy is to focus on technology that can be enhanced by AI/machine learning and has near-term or immediate commercial potential, particularly in the evolving internet of things (IoT) universe. With Travel Buddhi ready for a global roll-out, moving this technology forward will be a high priority in the first half of 2019.
mPhase recently filed its financial statements for the quarter ended December 31, 2018 , making the Company current in terms of its filing obligations. In lieu of a conference call, mPhase intends to put out a comprehensive corporate update in the near future to discuss its strategy for 2019. The Company would also like to direct shareholders to its newly revamped website at www.mphasetech.com and to the Travel Buddhi website at www.travelbuddhi.com.
About mPhase Technologies, Inc.
mPhase Technologies, Inc has historically engaged in technology R&D, with a particular emphasis on long-life, battery cell technology. The Company is currently transitioning into a consumer-oriented technology and services company.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words could, believe, anticipate, intend, estimate, expect, may, continue, predict, potential, project and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Companys filings with the U.S. Securities and Exchange Commission . Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Contacts:
Investor Contact:
ir@mphasetech.com
Source: mPhase Technologies, Inc.
GOIG LICENSE NEWS
Thursday, March 07 2019 8:30 AM, EST GOIP Global Receives Initial Approval for License to Grow Cannabis and Hemp in the Country of Kenya GlobeNewswire "Press Releases"
New York, NY , March 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GoIP Global Inc (otcpink:GOIG) announced today that the Company in seeking Cannabis licenses worldwide, has started the process in Kenya , where they have obtained the initial approval from the Ministry of Agriculture and is finalizing steps for licensing to export Cannabis. The current negotiations cover an initial lease of 500 acres for production, which can be expanded significantly. The lease term will be for 25 years. Kenya being on the equator provides the best conditions for year round production coupled with being a major agricultural export country, will allow Kenyan Cannabis production to fill the need for Medical and recreational Cannabis demand for the European Union and Canada .
The company expects to finalize the agreements in short order and contract to begin the process of growing, cultivating and exporting.
In other news, the company will not be changing its name to GoCanna as previously stated, the name met resistance from existing trademarks and the company has decided to pursue an alternative. The final decision on a name change will be made this month and all corporate material updated.
Mr. Ike Sutton stated, After visiting Kenya and meeting with officials in country, Im very excited about the prospects this agreement brings to our company. This is the first of several critical transactions that will transform GOIP into a relevant member of the burgeoning cannabis industry.
About GoIP Global GoIP Global is engaged in acquiring Hemp and Cannabis cultivation & export licenses, offering top tier management and developing partnerships for supply chain sales, and worldwide logistics pipelines. For more information, seewww.gocannaglobal.com.
Safe Harbor Statement Information in this news release may contain statements about future expectations, plans, prospects or performance of GoIP Global, Inc. that constitute forward-looking statements for purposes of the safe harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. GoIP Global, Inc. cautions you that any forward-looking information provided by or on behalf of GoIP Global, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. GoIP Global, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond GoIP Global, Inc.'s control. In addition to those discussed in GoIP Global, Inc.'s press releases, public filings, and statements by GoIP Global, Inc.'s management, including, but not limited to, GoIP Global, Inc.'s estimate of the sufficiency of its existing capital resources, GoIP Global, Inc.'s ability to raise additional capital to fund future operations, GoIP Global, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match GoIP Global, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. GoIP Global, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
Contact: GoIP Global Inc info@goip-global.com 1-833-644-4644
Source: GoIP Global, Inc.
FTEG NEW PRODUCT NEWS
Thursday, March 07 2019 8:25 AM, EST For The Earth Announces Launch of New Line of Premium CBD-Infused Topicals GlobeNewswire "Press Releases"
PHOENIX , March 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- For The Earth Corporation (the "Company" or "FTEG") (OTCMKTS: FTEG) is thrilled to announce the launch of its new line of premium pharmaceutical grade anti-aging Topical CBD Skin Care products under the brand designation "Clean Life". The line of products includes Day Cream , Night Cream , Eye Serum, Face Serum, and Face Mask, all infused with the Company's full spectrum THC-free CBD oil.
"Our analysis suggests that Topicals are the gateway product for mass adoption of CBD by the mainstream marketplace for consumable goods in North America ," noted CEO Nelson Grist . "The total CBD market is expected to bloom by more than a factor of 20 over the next three years according to some leading estimates. That process is going to be powered by mainstream adoption of CBD, which may be led by products like those we are launching today because people are already used to skin creams with exotic botanical elements. It's easier for the average person to discover CBD this way."
According to Cannabis Business Times, the market for CBD Topicals grew by 44% last year as mainstream adoption of skin care products containing CBD accelerated. The overall skin care products market is estimated to hit $148 billion next year, according to Statista research.
"We are building a vertically integrated model," continued Mr. Grist . "Our success is ultimately going to be a function of branding. We are different from the ground up. Our CBD products will carry our Clean Life brand designation and come from our own extraction process. Top to bottom, we are going to embody what we believe our customers will value most."
Management notes that this initial launch is in a product testing phase, and the Company wants its shareholders to test the new line of products to find out how potent and effective they are. Anyone interested in trying a sample of this new line is encouraged to email a request to: infofteg@gmail.com and include a name and address. The first 50 requests will receive a sample package (Face Mask is not included).
About For The Earth Corporation For The Earth Corporation is an emerging integrated CBD producer and retailer in the United States . The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint that includes multiple locations in Las Vegas and New York featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD markets. Two mall leases have been signed recently in Las Vegas , with another vending machine location secured in New York City . The Company plans to expand its New York vending machine penetration by the end of 2019. In addition, the Company has begun early-stage work to establish a state-of-the-art CBD extraction and production facility in Eugene, OR.
Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See For The Earth's filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Press & Media Inquiries: EHC Branding Agency Info@EHCBrandingAgency.com (626) MJ-BRAND
Corporate Contact: For The Earth Corporation 20 East Thomas Rd. Phoenix, AZ 85012 USA Contact: Nelson Grist Telephone: 602 502-0602 Email: infofteg@gmail.com
Source: For The Earth Corp.
Instadose Pharma Corp. Becomes The World’s Largest Cannabis Producer
“ Canadian based company Instadose Pharma Corp. has become the largest cultivator and pharmaceutical producer of CBD oil. The company received the only licence granted in the DRC to import, export, cultivate and process CBD oil from cannabis. Instadose Pharma is an agricultural and pharmaceutical firm that has
a partnership in traditional growing in the DRC for 5 years.”
“The land under cannabis cultivation is over 100,000 hectares, producing CBD Oil that is GMP certified and pharma grade 99.7% CBD. The company is the largest agricultural grower in the DRC and has a production capacity of 900,000 litres per year, with the largest agricultural presence in the entire DRC.”
Just a matter of time before the market realizes what is going on at this low pps
You can contact the company so that you don’t have to speculate.
Bid over 650 mil at 0002
Yes we can see clearly the small sells to paint it down throughout the day.
Solid day
Over $870,000 traded thus far
I understand you are basing the future off the past.
The company is headed in the right direction with today’s news and the market has proven it is forgiving despite the past when a company provides solid acquisitions.
COMMERCIAL BAKERY WEBSITE
https://commercialbakeries.com/
POINTS OF EMPHASIS IN TODAYS PR:
Tuesday, March 05 2019 10:56 AM, EST Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market GlobeNewswire "Press Releases"
TORONTO, ON , March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC:EAPH) announces that it has signed an agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months.
In its ongoing efforts to diversify and enter other lucrative sectors and add value-added businesses to achieve consistent growing sales to coincide with its revenue-generating framing contract and its pharmaceutical / diagnostic division, Easton is pleased to have signed an agreement to acquire a Toronto based commercial bakery and food preparation company which manufactures white labeled food products for third party food companies and its own line of niche food product lines, sold in major grocery chains, as well as specialty coffee chains. The company has an R&D division with product development and has begun discussions with licensed producers of cannabis, as well as food chains in order to develop and supply cannabis edible products.
Easton Pharmaceuticals and its management saw an opportunity to acquire a company with not only a proven track record, but also major expansion opportunities that can potentially grow its sales to over an estimated $50,000,000 per year. Eastons management will be implementing some changes that will increase the revenues to approximately $20,000,000 over the next 12 months.
Eastons CEO Evan Karras stated, We are extremely pleased to have signed a definitive agreement to acquire what we believe to be a successful commercial bakery and food preparation company, that together with their market knowledge and market share, and our expertise and infrastructure, we will be able to increase the sales fairly quickly.
Easton expects the transaction to be completed in the next 2 weeks as it is already with legal counsel for closing, but has already commenced a strategic transition plan. More information will be announced and disclosed once the transaction is completed.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton, together with BMV Medica S.A. own the exclusive distribution rights in Mexico and Latin America for two patented women's diagnostic products and a novel natural treatment for Bacterial Vaginosis, which they have sub-licensed to Bayer and Gedeon Richter . In addition, a generic cancer drugs line is being developed for sale in Mexico . The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs. As part of its strategic growth plan, the Company will be entering new lucrative market segments globally, including Gaming, Real Estate Development and Hospitality and Food and Beverage, among others.
For More Information on Easton and Affiliated and Partner Company's Visit:
http://www.eastonpharmaceuticalsinc.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
CONTACT INFORMATION Evan Karras / CEO / President Tel: +1 (647) 362-5700 Email:eastonpharma@protonmail.com www.eastonpharmaceuticalsinc.com
Source: Easton Pharmaceuticals Inc.
EAPH NEWS
Tuesday, March 05 2019 10:56 AM, EST Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market GlobeNewswire "Press Releases"
TORONTO, ON , March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC:EAPH) announces that it has signed an agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months.
In its ongoing efforts to diversify and enter other lucrative sectors and add value-added businesses to achieve consistent growing sales to coincide with its revenue-generating framing contract and its pharmaceutical / diagnostic division, Easton is pleased to have signed an agreement to acquire a Toronto based commercial bakery and food preparation company which manufactures white labeled food products for third party food companies and its own line of niche food product lines, sold in major grocery chains, as well as specialty coffee chains. The company has an R&D division with product development and has begun discussions with licensed producers of cannabis, as well as food chains in order to develop and supply cannabis edible products.
Easton Pharmaceuticals and its management saw an opportunity to acquire a company with not only a proven track record, but also major expansion opportunities that can potentially grow its sales to over an estimated $50,000,000 per year. Eastons management will be implementing some changes that will increase the revenues to approximately $20,000,000 over the next 12 months.
Eastons CEO Evan Karras stated, We are extremely pleased to have signed a definitive agreement to acquire what we believe to be a successful commercial bakery and food preparation company, that together with their market knowledge and market share, and our expertise and infrastructure, we will be able to increase the sales fairly quickly.
Easton expects the transaction to be completed in the next 2 weeks as it is already with legal counsel for closing, but has already commenced a strategic transition plan. More information will be announced and disclosed once the transaction is completed.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton, together with BMV Medica S.A. own the exclusive distribution rights in Mexico and Latin America for two patented women's diagnostic products and a novel natural treatment for Bacterial Vaginosis, which they have sub-licensed to Bayer and Gedeon Richter . In addition, a generic cancer drugs line is being developed for sale in Mexico . The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs. As part of its strategic growth plan, the Company will be entering new lucrative market segments globally, including Gaming, Real Estate Development and Hospitality and Food and Beverage, among others.
For More Information on Easton and Affiliated and Partner Company's Visit:
http://www.eastonpharmaceuticalsinc.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
CONTACT INFORMATION Evan Karras / CEO / President Tel: +1 (647) 362-5700 Email:eastonpharma@protonmail.com www.eastonpharmaceuticalsinc.com
Source: Easton Pharmaceuticals Inc.
Thank you for bringing this info to the light.
GNCP 3-4-19
The Current Board of Directors of GNCC Capital, Inc.* (“GNCC” or “the Company”), quoted on the OTC Markets under the Trading Symbol “GNCP” confirm that:
*The Current Directors depart the GNCC Board of Directors on or before March 31, 2019 (close of the Transition Period).
In the interests of greater transparency, GNCC’s Current Directors and the BioCann Pharma Group Management have today authorized their Transfer Agent to supply “live” information of our issued and outstanding shares of Common Stock. This will result in our Company having a “Transfer Agent Verified” logo on www.otcmarkets.com, indicating that the information is reliable and trustworthy. It is anticipated that this will be reflected within days given that our Transfer Agent is uploading the data today.
This provides our shareholders with true and accurate numbers of issued and outstanding shares of Common Stock, negating the need for shareholders to contact the Transfer Agent directly.
THE OTC MARKETS GROUP “Transfer Agent Verified Shares Program”
The Transfer Agent Verified Shares Program provides reliable share data to investors of OTCQX, OTCQB and Pink securities by allowing participating transfer agents to submit verified shares outstanding information on a regular basis for their clients directly to OTC Markets Group.
Effective January 1, 2019, U.S. OTCQX and OTCQB companies will be required to provide verified share data through a transfer agent who participates in the Transfer Agent Verified Shares Program. OTC Markets Group will also use this data to confirm compliance with OTCQX and OTCQB market rules.
Whilst GNCC is not quoted on either of the OTCQX nor OTCQB Markets, this was a voluntary decision taken by your Current Directors and by BioCann Pharma Management.
DATED: MARCH 4, 2019
RONALD YADIN LOWENTHAL GNCC CAPITAL, INC. EXECUTIVE CHAIRMAN
NICOLAAS EDWARD BLOM
GNCC CAPITAL, INC.
PRESIDENT & CHIEF OPERATING OFFICER
Gncp update out!
FTEG NEWS
Monday, March 04 2019 8:31 AM, EST For The Earth Announces Groundbreaking CBD Partnership with Fastcorp Vending in the $30B Vending Space GlobeNewswire "Press Releases"
PHOENIX , March 04, 2019 (GLOBE NEWSWIRE) -- (WWW.OTCMASSMEDIA.COM) For The Earth Corporation (the Company or FTEG) (OTCMKTS: FTEG) is excited to announce that it has entered into a strategic partnership with Fastcorp Vending (Fastcorp), the world leader in frozen vending machine sales and a pioneer of innovative vending technology systems armed with advanced robotics.
According to management, the partnership will augment the Companys mission to become the leader in the CBD vending machine market, which will augment its traditional CBD stores, mall kiosks, and e-commerce sales portals.
100 million Americans will use one of 7 million vending machines each day, noted the Companys CEO, Nelson Grist . The CBD market is poised for massive growth according to all available analysis, and automated vending machines clearly represent the most cost-efficient and highest-margin means of distribution for CBD. Our research suggests that CBD vending machines can be positioned according to consumer behavior patterns based on accessibility and demand. And, once established, the overhead is negligible. In short, we are thrilled to partner with the top innovator in the vending machine technology market.
Fastcorp vending technology (fastcorpvending.com) features advanced robotics, WIFI network capability, seamless touchscreen interfaces, and advanced cashless payment options including Apple Pay and Google Pay.
Fastcorp CEO, Brian Weinstein , commented, We are excited to be partnering with For The Earth in this emerging CBD market. This partnership aligns perfectly with our strategic objectives and we are confident that our technology is a perfect fit for their present and future needs.
FTEG management also believes that the CBD market suffers from a taboo limitation for some consumers due to its association with the cannabis plant. That suggests many consumers interested in CBD may favor a means of consumption that does not necessitate interacting with a full-service in-store purchase process. Vending machines may offer a strong alternative solution for such individuals.
Mr. Grist continued, We are pressing aggressively at both ends of the equation right now: establishing our own extraction and production operation and broadening our interface with the end-market consumer. Nailing into place the best vending machine partner and strategy is a huge part of successfully navigating that equation.
About For The Earth Corporation For The Earth Corporation is an emerging integrated CBD producer and retailer in the United States . The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint that includes multiple locations in Las Vegas and New York featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD markets. Two mall leases have been signed recently in Las Vegas , with another vending machine location secured in New York City . The Company plans to expand its New York vending machine penetration by the end of 2019. In addition, the Company has begun early-stage work to establish a state-of-the-art CBD extraction and production facility in Eugene, OR.
About Fastcorp Vending Fastcorp Vending has been an industry leader in robotic retail and vending technology for decades. The DIVI machine contains the worlds most versatile and customizable technology, allowing endless possibilities in the automated retail space. Fastcorp Vending works with brands to create specific solutions that cater to their customers. Using our unique product storage and delivery system, the customer is presented with a contemporary user experience unlike that of a conventional vending machine.
Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See For The Earths filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Press & Media Inquiries: EHC Branding Agency Info@EHCBrandingAgency.com (626) MJ-BRAND
Corporate Contact: For The Earth Corporation 20 East Thomas Rd. Phoenix, AZ 85012 USA Contact: Nelson Grist Telephone: 602 502-0602 Email: infofteg@gmail.com
Source: For The Earth Corp.
VYST NEWS
Monday, March 04 2019 8:23 AM, EST Vystar Receives Second European Patent for Reduced Allergenicity Natural Rubber Latex GlobeNewswire "Press Releases"
Vystars Vytex deproteinization method reduces allergenicity and odor,
Manufacturing process uses less water, chemical and dyes for naturally, purer, whiter and stronger latex
WORCESTER, Mass. , March 04, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) has been granted European, EP Patent No. 2238183 entitled Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same. Vystar now holds 13 foreign and 4 U.S. patents related to its latex deproteinization process for the production of Vytex , a natural rubber latex (NRL) that is virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions to latex from direct contact.
This patent extends important intellectual property (IP) protection for Vystar in the production and distribution of Vytex to Europe using the Vytex formula to meet the growing demand for low protein NRL for products including balloons, examination and surgical gloves, condoms, breather bags, latex tubing, probe covers, catheters, threads, foams, cold seal and pressure sensitive adhesives, stated Steve Rotman , CEO of Vystar .
Rotman continues, This new patent extends our coverage for a decade and we have now broadened our protected areas in Europe to include additional manufacturing areas. While we have had broad protection for methods of deproteinization to reduce allergenicity, we now have further coverage for end products as well. We are particularly pleased to have added protection in Germany , The United Kingdom , France , Spain and Italy , which account for much of latex product manufacturing in Europe.
Latex allergies are a major concern in many peoples daily lives. Globally, 4.3% of people have latex allergies. The rate rises to 10-17% for healthcare workers, according to the Journal of Occupational Health . Symptoms of a latex allergy can be mild, such as rashes or itchy eyes. But in some people, latex elicits a serious, and potentiallylife-threatening, allergic reaction. While anyone can develop a latex allergy, some people are more at risk than others due to frequent contact with latex and certain related health conditions.
Despite the increased risk of latex allergies, NRL medical gloves are preferred over synthetic latex and vinyl by surgeons and medical professionals due to NRLs superior tactile sensitivity, puncture resistance, strength, durability and flexibility. This presents a tremendous market opportunity for Vytex as Vytex is virtually free of allergy-causing proteins while providing all the benefits of latex.
The Vytex deproteinization process removes the odor-causing latex proteins, eliminating the strong odor of traditional latex and creating a stronger latex bond that increases its durability, strength, elasticity. and bright white Vytex deproteinization process makes it more eco-friendly than its competitors, as there is no need for traditional water rinses or fragrance to address the odor or the addition of dyes or bleaches to improve whiteness. Vytex is sustainably sourced and completely biodegradable, in sharp contrast to petrochemical based memory foam, vinyl and synthetic latex
Vytex is currently used in multiple mattress lines, including the new Vytex Cloud Bed-In-A-Box now available at Rotmans Furniture Store and Rotmans.com; mattress brands including Natura, Gold Bond, and Spring Air ; Jeffco-manufactured components for toppers and mattresses, which are sold to multiple manufacturers; and private label pillows, toppers and mattresses sold online via sites such as Amazon and Bed Bath & Beyond. Vytex is also used in industrial adhesives, apparel padding and threads, shoes, sports equipment and electrical gloves. Vystar continues development of new Vytex formulations and is seeking additional manufacturing and development partners for numerous products. Contact Steve Rotman at 508-791-9114 or srotman@vytex.com.
Videos on Vystar and products made with Vytex are available at: https://www.vytex.com/blog/category/videos/
About Vystar Corporation : Based in Worcester, Mass. , Vystar Corp. (OTC Pink: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products, and the owner of RxAir UV light air purification products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. For more information, visit www.vytex.com.
Contacts: Media: Julie Shepherd , Accentuate PR, 847 275 3643, Julie@accentuatepr.com Investors: Steven Rotman , Vystar CEO, 508-791-9114, srotman@vytex.com
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
Source: Vystar Corp
GNCP ADDED A UPDATE TO THE OTC MARKETS TODAY
https://backend.otcmarkets.com/otcapi/company/financial-report/212957/content
The Current Board of Directors of GNCC Capital, Inc.* (“GNCC” or “the Company”), quoted on the OTC Markets under the Trading Symbol “GNCP” confirm that; *The Current Directors depart the GNCC Board of Directors on or before March 31, 2019 (close of the Transition Period). During the Transition Period, the Current Directors will: a) Ensure that all outstanding Quarterly and Annual Reports are completed and filed to restore the Company to a “CURRENT FILER” and on the OTC Markets; and b) Deal with the Company’s Mining Exploration Interests and cancel all issued and outstanding shares of secured Classes of Preferred Common Stock; and c) Only issue Press Releases that pertain to (a) and (b) as above-mentioned. During the Transition Period, the BioCann Pharma Group Management will: a) Introduce and familiarize the GNCC Shareholders and Investors to their business, its prospects, their Management and all other pertinent information. This they will do through Press Releases*; and b) Complete the necessary web sites to better explain their business; and c) Appoint (one) Director to the Board of GNCC during this coming week. *To best explain the “communication process” and timing of Press Releases, we summarize as follows: BioCann Pharma is a part of a large organization which is interlinked with “overlapping Management functions”, Partnerships as well as direct and indirect Joint Venture Agreements in the Republic of Colombia. Their primary Partner Company operates in other Countries in addition to the Republic of Colombia. The BioCann Pharma Group Executives operate primarily from two areas in the Republic of Colombia as well in Ontario, Canada; certain other key Executives are based in three additional countries. The new GNCC Board of Directors on March 31, 2019 will be comprised of BioCann Pharma Group Executives as well Executives from their Partnerships and Joint Ventures. Given the various time zones between your Current Directors being in Johannesburg, South Africa, BioCann Pharma Group Executives travelling and being based in different time zones, “mutually agreed upon” Press Releases are taking as long as 3 (Three) business days to be drafted, facts and statements verified and then approved by all of the parties.
3 | Page
ACTIONS BEING UNDERTAKEN THIS WEEK: Following discussions with BioCann Pharma Group and their Head of Corporate Finance, your Current Directors can now confirm that during this week, shareholders should expect the following: i) The first BioCann Pharma Group Executive being appointed to the GNCC Board; and ii) No less that 2 (Two) initial detailed Press Releases prepared by BioCann Pharma Group and verified and approved by the Current Directors of GNCC; being published. iii) The Current Directors cannot possibly issue a BioCann Press Release tomorrow, Monday March 3, 2019; solely due to time differences and travel schedules. We only mention this as a number of shareholders appear to expecting a Press Release tomorrow. FINALLY: As always, your Current Directors strongly urge shareholders to reach out to us for facts; wild speculation coupled with false and/or misleading information being posted on Internet Stock Forums; is honestly just that. Shareholders should base their investment and/or trading decisions solely upon BioCann Pharma Group Management commentary. DATED: MARCH 3, 2019
RONALD YADIN LOWENTHAL GNCC CAPITAL, INC. EXECUTIVE CHAIRMAN
NICOLAAS EDWARD BLOM GNCC CAPITAL, INC. PRESIDENT & CHIEF OPERATING OFFICER
Good to see you positive .
LIBE 8-K OUT
http://archive.fast-edgar.com//20190301/A32ZT62CZ22RNZS2222H2ZX2EL7SZZ22QBB2/
Friday, March 01 2019 4:49 PM, EST LIBERATED SOLUTIONS, INC. FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Financial Statements and Exhibits Edgar Online "Glimpses"
Item 1.01 Entry into a Material Definitive Agreement.
On February 28, 2019 , the Company entered into a Stock Purchase Agreement (the "SPA") with CigaWatt, Inc. ("CigaWatt") and the shareholders of CigaWatt to purchase 100% of the outstanding shares of capital stock of CigaWatt in exchange for $200,000 . The SPA is expected to close on May 15, 2019 (or on such other date as the Company and CigaWatt agree) pending certain closing conditions, which include, but are not not limited to, completion of an audit of CigaWatt's financial statements.
The foregoing information is a summary of the SPA described above, is not complete, and is qualified in its entirety by reference to the full text of the SPA, which is attached as Exhibit 10.1 to this Current Report on Form 8-K. Readers should review the SPA for a complete understanding of the terms and conditions of the transaction described above.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 10.1 Stock Purchase Agreement between the Company and CigaWatt dated February 28, 2019
FTEG NEWS
Friday, March 01 2019 4:00 PM, EST For The Earth Corporation Provides Acquisition Update GlobeNewswire "Press Releases"
PHOENIX, AZ , March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE For The Earth Corporation (the Company) (OTC: FTEG) is excited to provide acquisition update.
Acquisitions Update:
I would like to comment on the latest announcement regarding For The Earths acquisition of the Chow brand. As we all know, when one company acquires another (or when a company is only acquiring another companies brand name), there is always apprehension from both parties. After the agreement was signed, I decided it wasnt the right fit for FTEG. The number of vending machines that Vlisos management team wanted to launch {in 2019} was extremely aggressive. This in turn would not allow for other acquisitions, development of new products, and marketing campaigns. It would not support FTEG in creating strong revenues and would have forced our focus from long term shareholder value. We will concentrate efforts on the launch of our Las Vegas vending machines, kiosks and inline retail store, said Nelson Grist , President and CEO of For The Earth Corporation . Vlsio is a great startup company, with great a management team who are young and highly skilled, I wish them well!
If you have any questions, please send an email to the FTEG Investment Team.
infofteg@gmail.com
About For The Earth Corporation
For The Earth Corporation is an emerging integrated CBD producer and retailer in the United States . The Company is in the process of establishing a vertical framework that will extend from cultivation to extraction and production to a strategic retail footprint. that includes multiple locations, featuring mall kiosks, vending machines, e-commerce, and full store locations serving both the human and pet CBD markets. Two mall leases have been signed recently in Las Vegas , with another vending machine location secured in New York City . The Company plans to expand its New York vending machine penetration by the end of 2019. In addition, the Company has begun early-stage work to establish a state-of-the-art CBD extraction and production facility in Eugene, OR.
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See For The Earths filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Press & Media Inquiries: EHC Branding Agency Info@EHCBrandingAgency.com (626) MJ-BRAND For The Earth Corporation 20 E Thomas Rd. Phoenix, AZ 85012 USA Contact: Nelson Grist Telephone: 602 502-0602 Email: infofteg@gmail.com
Source: For The Earth Corp.
Fteg news out
“After the agreement was signed I decided it was not the right fit for fteg”